Enrichment methods and clinical application of circulating tumor cells

Abstract

Ning Dawei, Ou Yang, Cui Kai, Li Sheng, Gao Dehai. Enrichment methods and clinical application of circulating tumor cells[J]. Journal of International Oncology, 2021, 48(3): 167-171.

References34

[1]	Hong B, Zu Y. Detecting circulating tumor cells: current challenges and new trends[J]. Theranostics, 2013,3(6):377-394. DOI: 10.7150/thno.5195. doi:10.7150/thno.5195pmid:23781285
[2]	Martin OA, Anderson RL, Narayan K, et al. Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?[J]. Nat Rev Clin Oncol, 2017,14(1):32-44. DOI: 10.1038/nrclinonc.2016.128. doi:10.1038/nrclinonc.2016.128pmid:27550857
[3]	Krantz BA, O'Reilly EM. Biomarker-based therapy in pancreatic ductal adenocarcinoma: an emerging reality?[J]. Clin Cancer Res, 2018,24(10):2241-2250. DOI: 10.1158/1078-0432.CCR-16-3169. doi:10.1158/1078-0432.CCR-16-3169pmid:29269376
[4]	Anderson KJ, de Guillebon A, Hughes AD, et al. Effect of circula-ting tumor cell aggregate configuration on hemodynamic transport and wall contact[J]. Math Biosci, 2017,294:181-194. DOI: 10.1016/j.mbs.2017.10.002. pmid:29024748
[5]	Kaifi JT, Kunkel M, Das A, et al. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques[J]. Cancer Biol Ther, 2015,16(5):699-708. DOI: 10.1080/15384047.2015.1030556. doi:10.1080/15384047.2015.1030556pmid:25807199
[6]	Boyer M, Cayrefourcq L, Garima F, et al. Circulating tumor cell detection and polyomavirus status in merkel cell carcinoma[J]. Sci Rep, 2020,10(1):1612. DOI: 10.1038/s41598-020-58572-9. doi:10.1038/s41598-020-58572-9pmid:32005907
[7]	Tamminga M, Andree KC, Hiltermann TJN, et al. Detection of circulating tumor cells in the diagnostic leukapheresis product of non-small-cell lung cancer patients comparing CellSearch^®and ISET [J]. Cancers (Basel), 2020,12(4):896. DOI: 10.3390/cancers12040896. doi:10.3390/cancers12040896
[8]	Kallergi G, Politaki E, Alkahtani S, et al. Evaluation of isolation methods for circulating tumor cells (CTCs)[J]. Cell Physiol Biochem, 2016,40(3-4):411-419. DOI: 10.1159/000452556. pmid:27889762
[9]	Nanou A, Crespo M, Flohr P, et al. Scanning electron microscopy of circulating tumor cells and tumor-derived extracellular vesicles[J]. Cancers (Basel), 2018,10(11):416. DOI: 10.3390/cancers10110416. doi:10.3390/cancers10110416
[10]	Xu X, Jiang Z, Wang J, et al. Microfluidic applications on circula-ting tumor cell isolation and biomimicking of cancer metastasis[J]. Electrophoresis, 2020,41(10-11):933-951. DOI: 10.1002/elps.201900402. doi:10.1002/elps.201900402pmid:32144938
[11]	Le Du F, Fujii T, Kida K, et al. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream^®in patients with breast cancer treated with primary systemic therapy [J]. PLoS One, 2020,15(3):e0229903. DOI: 10.1371/journal.pone.0229903. doi:10.1371/journal.pone.0229903pmid:32214335
[12]	Xie N, Hu Z, Tian C, et al. In vivo detection of CTC and CTC plakoglobin status helps predict prognosis in patients with metastatic breast cancer[J]. Pathol Oncol Res, 2020,26(4):2435-2442. DOI: 10.1007/s12253-020-00847-7. doi:10.1007/s12253-020-00847-7pmid:32557169
[13]	Tang S, Shen H, Hao Y, et al. A novel cytosensor based on Pt@Ag nanoflowers and AuNPs/Acetylene black for ultrasensitive and highly specific detection of circulating tumor cells[J]. Biosens Bioelectron, 2018,104:72-78. DOI: 10.1016/j.bios.2018.01.001. doi:10.1016/j.bios.2018.01.001pmid:29324284
[14]	Andree KC, van Dalum G, Terstappen LW. Challenges in circula-ting tumor cell detection by the CellSearch system[J]. Mol Oncol, 2016,10(3):395-407. DOI: 10.1016/j.molonc.2015.12.002. pmid:26795350
[15]	Zhou BY, Gong JH, Cai XY, et al. An imbalance between stellate cells and γδT cells contributes to hepatocellular carcinoma aggressiveness and recurrence[J]. Hepatol Int, 2019,13(5):631-640. DOI: 10.1007/s12072-019-09969-w. doi:10.1007/s12072-019-09969-wpmid:31342250
[16]	Tamminga M, de Wit S, van de Wauwer C, et al. Analysis of released circulating tumor cells during surgery for non-small cell lung cancer[J]. Clin Cancer Res, 2020,26(7):1656-1666. DOI: 10.1158/1078-0432.CCR-19-2541. doi:10.1158/1078-0432.CCR-19-2541pmid:31772122
[17]	Cie'slikowski WA, Budna-Tukan J, 'Swierczewska M, et al. Circulating tumor cells as a marker of disseminated disease in patients with newly diagnosed high-risk prostate cancer[J]. Cancers (Basel), 2020,12(1):160. DOI: 10.3390/cancers12010160. doi:10.3390/cancers12010160
[18]	Costa C, Dávila-Ibáñez AB. Methodology for the isolation and analysis of CTCs [J]. Adv Exp Med Biol, 2020,1220:45-59. DOI: 10.1007/978-3-030-35805-1_4. doi:10.1007/978-3-030-35805-1_4pmid:32304079
[19]	Buscail E, Alix-Panabières C, Quincy P, et al. High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery[J]. Cancers (Basel), 2019,11(11):1656. DOI: 10.3390/cancers11111656. doi:10.3390/cancers11111656
[20]	Rawal S, Yang YP, Cote R, et al. Identification and quantitation of circulating tumor cells[J]. Annu Rev Anal Chem (Palo Alto Calif), 2017,10(1):321-343. DOI: 10.1146/annurev-anchem-061516-045405. doi:10.1146/annurev-anchem-061516-045405
[21]	Mathur L, Ballinger M, Utharala R, et al. Microfluidics as an enabling technology for personalized cancer therapy[J]. Small, 2020,16(9):e1904321. DOI: 10.1002/smll.201904321. doi:10.1002/smll.201904321pmid:31747127
[22]	Hvichia GE, Parveen Z, Wagner C, et al. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells[J]. Int J Cancer, 2016,138(12):2894-2904. DOI: 10.1002/ijc.30007. doi:10.1002/ijc.30007pmid:26789903
[23]	Gao R, Cheng L, Wang S, et al. Efficient separation of tumor cells from untreated whole blood using a novel multistage hydrodynamic focusing microfluidics[J]. Talanta, 2020,207:120261. DOI: 10.1016/j.talanta.2019.120261. doi:10.1016/j.talanta.2019.120261pmid:31594567
[24]	Lin Z, Luo G, Du W, et al. Recent advances in microfluidic platforms applied in cancer metastasis: circulating tumor cells' (CTCs) isolation and tumor-on-a-chip[J]. Small, 2020,16(9):e1903899. DOI: 10.1002/smll.201903899. pmid:31747120
[25]	Jin L, Zhao W, Zhang J, et al. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter^®CTC capture system in patients with breast cancer [J]. Cancer Med, 2020,9(5):1638-1647. DOI: 10.1002/cam4.2825. doi:10.1002/cam4.2825pmid:31908156
[26]	Cristofanilli M, Pierga JY, Reuben J, et al. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): international expert consensus paper[J]. Crit Rev Oncol Hematol, 2019,134:39-45. DOI: 10.1016/j.critrevonc.2018.12.004. doi:10.1016/j.critrevonc.2018.12.004pmid:30771872
[27]	Dianat-Moghadam H, Azizi M, Eslami-S Z, et al. The role of circulating tumor cells in the metastatic cascade: biology, technical challenges, and clinical relevance[J]. Cancers (Basel), 2020,12(4):867. DOI: 10.3390/cancers12040867. doi:10.3390/cancers12040867
[28]	Yin W, Zhu J, Ma B, et al. Overcoming obstacles in pathological diagnosis of pulmonary nodules through circulating tumor cell enrichment[J]. Small, 2020,16(25):e2001695. DOI: 10.1002/smll.202001695. doi:10.1002/smll.202001695pmid:32452626
[29]	Moon SM, Kim JH, Kim SK, et al. Clinical utility of combined circulating tumor cell and circulating tumor DNA assays for diagnosis of primary lung cancer[J]. Anticancer Res, 2020,40(6):3435-3444. DOI: 10.21873/anticanres.14329. doi:10.21873/anticanres.14329pmid:32487642
[30]	Yuan D, Chen L, Li M, et al. Isolation and characterization of circulating tumor cells from human gastric cancer patients[J]. J Cancer Res Clin Oncol, 2015,141(4):647-660. DOI: 10.1007/s00432-014-1814-0. doi:10.1007/s00432-014-1814-0pmid:25326346
[31]	Cui S, Ni Y, Zhao Y, et al. Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors[J]. Lung Cancer, 2019,132:45-53. DOI: 10.1016/j.lungcan.2019.04.003. doi:10.1016/j.lungcan.2019.04.003pmid:31097093
[32]	Okabe H, Tsunoda S, Hosogi H, et al. Circulating tumor cells as an independent predictor of survival in advanced gastric cancer[J]. Ann Surg Oncol, 2015,22(12):3954-3961. DOI: 10.1245/s10434-015-4483-6. doi:10.1245/s10434-015-4483-6pmid:25777087
[33]	Li Y, Gong J, Zhang Q, et al. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer[J]. Br J Cancer, 2016,114(2):138-145. DOI: 10.1038/bjc.2015.417. doi:10.1038/bjc.2015.417pmid:26784122
[34]	Zheng X, Fan L, Zhou P, et al. Detection of circulating tumor cells and circulating tumor microemboli in gastric cancer[J]. Transl Oncol, 2017,10(3):431-441. DOI: 10.1016/j.tranon.2017.02.007. pmid:28448959

Enrichment methods and clinical application of circulating tumor cells

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References34

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[3]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[4]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[5]	Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165.
[6]	Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng.Imaging diagnosis， pathological upgrade， and imaging technology progress of ductal carcinomain situof the breast[J]. Journal of International Oncology, 2024, 51(3): 166-169.
[7]	Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180.
[8]	Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185.
[9]	Liu Bohan, Huang Junxing.Research progress of liquid biopsy technology in esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(2): 105-108.
[10]	Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(2): 89-94.
[11]	Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104.
[12]	Huang Zhen, Chen Yongshun.Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma[J]. Journal of International Oncology, 2024, 51(1): 59-64.
[13]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[14]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）[J]. Journal of International Oncology, 2023, 50(7): 385-397.
[15]	Ju Yifan, Xu Chenyang, Lei Dapeng.Research progress of pathomics in head and neck neoplasms[J]. Journal of International Oncology, 2023, 50(5): 294-298.